Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Jonathan_Solomon
|
| gptkbp:country |
gptkb:Israel
|
| gptkbp:developedBy |
therapies for chronic diseases
therapies for cystic fibrosis therapies for inflammatory bowel disease |
| gptkbp:focusesOn |
phage therapy
microbiome-based therapeutics |
| gptkbp:foundedYear |
2015
|
| gptkbp:founder |
gptkb:Assaf_Oron
gptkb:Eran_Elinav gptkb:Rotem_Sorek |
| gptkbp:headquartersLocation |
gptkb:Ness_Ziona,_Israel
|
| https://www.w3.org/2000/01/rdf-schema#label |
BiomX
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:listedOn |
gptkb:NYSE_American
|
| gptkbp:publiclyTraded |
true
|
| gptkbp:researchInterest |
bacteriophage-based drugs
|
| gptkbp:stockSymbol |
gptkb:PHGE
|
| gptkbp:tradedOn |
gptkb:NYSE_American:_PHGE
|
| gptkbp:website |
https://www.biomx.com/
|
| gptkbp:bfsParent |
gptkb:Seventure_Partners
|
| gptkbp:bfsLayer |
6
|